中华泌尿外科杂志
中華泌尿外科雜誌
중화비뇨외과잡지
CHINESE JOURNAL OF UROLOGY
2011年
9期
643-646
,共4页
陈晔%邓燕青%陈捷%李森%张春芳%王佳%徐涛%王晓峰
陳曄%鄧燕青%陳捷%李森%張春芳%王佳%徐濤%王曉峰
진엽%산연청%진첩%리삼%장춘방%왕가%서도%왕효봉
自我管理干预%良性前列腺增生%下尿路症状
自我管理榦預%良性前列腺增生%下尿路癥狀
자아관리간예%량성전렬선증생%하뇨로증상
Self-management intervention%Benign prostatic hyperplasia%Low urinary tract symptoms
目的 评估自我管理干预(SMI)对良性前列腺增生(BPH)患者改善下尿路症状(LUTS)症状及生活质量的作用。 方法 选择2008年3月至2009年9月服用α受体阻滞剂＞3个月的BPH患者222例，随机分为SMI组和对照组。SMI组119例，年龄54～90岁，平均71岁；对照组103例，年龄54～89岁，平均69岁。在入组、1周、3个月、6个月时，采用IPSS、QOL对2组患者进行评价。 结果 2组患者均获得全程随访，在人组及第1周时，SMI组IPSS为20.5和20.5，QOL为50.9和50.8；对照组IPSS为19.6和19.3，QOL为51.1和51.1,2组间比较差异均无统计学意义(P＞0.05)。第3、6个月时，SMI组IPSS为14.3和12.0，QOL为36.7和29.8，低于干预前得分，也低于对照组的IPSS 19.7及19.9和QOL 50.6和50.2，2组间比较差异有统计学意义(P＜0.05)。 结论 采用SMI可明显减轻服药期间BPH患者的LUTS症状，提高生活质量。
目的 評估自我管理榦預(SMI)對良性前列腺增生(BPH)患者改善下尿路癥狀(LUTS)癥狀及生活質量的作用。 方法 選擇2008年3月至2009年9月服用α受體阻滯劑＞3箇月的BPH患者222例，隨機分為SMI組和對照組。SMI組119例，年齡54～90歲，平均71歲；對照組103例，年齡54～89歲，平均69歲。在入組、1週、3箇月、6箇月時，採用IPSS、QOL對2組患者進行評價。 結果 2組患者均穫得全程隨訪，在人組及第1週時，SMI組IPSS為20.5和20.5，QOL為50.9和50.8；對照組IPSS為19.6和19.3，QOL為51.1和51.1,2組間比較差異均無統計學意義(P＞0.05)。第3、6箇月時，SMI組IPSS為14.3和12.0，QOL為36.7和29.8，低于榦預前得分，也低于對照組的IPSS 19.7及19.9和QOL 50.6和50.2，2組間比較差異有統計學意義(P＜0.05)。 結論 採用SMI可明顯減輕服藥期間BPH患者的LUTS癥狀，提高生活質量。
목적 평고자아관리간예(SMI)대량성전렬선증생(BPH)환자개선하뇨로증상(LUTS)증상급생활질량적작용。 방법 선택2008년3월지2009년9월복용α수체조체제＞3개월적BPH환자222례，수궤분위SMI조화대조조。SMI조119례，년령54～90세，평균71세；대조조103례，년령54～89세，평균69세。재입조、1주、3개월、6개월시，채용IPSS、QOL대2조환자진행평개。 결과 2조환자균획득전정수방，재인조급제1주시，SMI조IPSS위20.5화20.5，QOL위50.9화50.8；대조조IPSS위19.6화19.3，QOL위51.1화51.1,2조간비교차이균무통계학의의(P＞0.05)。제3、6개월시，SMI조IPSS위14.3화12.0，QOL위36.7화29.8，저우간예전득분，야저우대조조적IPSS 19.7급19.9화QOL 50.6화50.2，2조간비교차이유통계학의의(P＜0.05)。 결론 채용SMI가명현감경복약기간BPH환자적LUTS증상，제고생활질량。
ObjectiveTo evaluate the efficacy of self-management to improve the lower urinary tract symptoms (LUTS) and life quality in benign prostatic hyperplasia (BPH) patients. Methods Two hundred and twenty-two men were recruited to take αblockers for at least 3 months from March 2008 to September 2009. Participants were randomized to either attend a self-management program in addition to standard care or to standard care alone. Difference of scores of International Prostate Symptom Score (IPSS) and BPH-specific quality of life scale between the two groups was analyzed during enrollment period, the 1st week, the 3rd month and 6th month of therapy.Results All participants were followed up for 6 months.The IPSS scores of the SMI group were 20.5 and 20.5 and the QOL were 50.9 and 50.8 at the 1st week.While the numbers were 19.6 and 19.3 for IPSS and 51.1 and 51.1 for QOL in the control group. There was no statistic difference in the control group. Whereas during the 3rd and 6th month assessment, the scores of IPSS and quality of life of self-management interventional group were statistically significantly lower than those of the control group.Conclusions Self-management intervention could reduce the LUTS symptoms and improve quality of life in BPH patients who were taking medicines.
